Aprea Therapeutics, Inc. (APRE)

Aprea Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	26.25	21.61	28.79	53.08	-
Cash & Short-Term Investments	26.25	21.61	28.79	53.08	-
Cash Growth	3.53%	-24.94%	-45.76%	-	-
Prepaid Expenses	0.23	0.91	1.37	3.51	-
Total Current Assets	26.48	22.52	30.15	56.58	-
Property, Plant & Equipment	0.09	0.09	0	0.21	-
Other Long-Term Assets	0.32	0.04	-	0.03	-
Total Assets	26.89	22.65	30.16	56.82	-
Accounts Payable	1.15	1.67	0.84	1.77	-
Accrued Expenses	2.48	2.19	2.36	5.35	-
Current Portion of Leases	-	-	-	0.19	-
Current Unearned Revenue	-	0.53	-	-	-
Total Current Liabilities	3.64	4.39	3.2	7.32	-
Total Liabilities	3.64	4.39	3.2	7.32	-
Common Stock	0.01	0	0	0	-
Additional Paid-In Capital	350.69	335.64	330.06	241	-
Retained Earnings	-318.15	-308.08	-293.8	-181.13	-
Comprehensive Income & Other	-10.6	-10.61	-10.62	-10.36	-
Total Common Equity	21.95	16.95	25.64	49.51	-
Shareholders' Equity	23.26	18.26	26.95	49.51	-
Total Liabilities & Equity	26.89	22.65	30.16	56.82	-
Total Debt	-	-	-	0.19	-
Net Cash (Debt)	26.25	21.61	28.79	52.89	-
Net Cash Growth	3.53%	-24.94%	-45.57%	-	-
Net Cash Per Share	5.30	5.97	17.37	49.69	-
Filing Date Shares Outstanding	5.43	5.43	3.73	1.06	1.06
Total Common Shares Outstanding	5.43	3.74	2.66	1.06	1.06
Working Capital	22.85	18.14	26.95	49.27	-
Book Value Per Share	4.04	4.54	9.66	45.97	-
Tangible Book Value	21.95	16.95	25.64	49.51	-
Tangible Book Value Per Share	4.04	4.54	9.66	45.97	-
Machinery	-	0.14	0.05	0.14	-

Source: S&P Capital IQ. Standard template. Financial Sources.